AAAAAA

   
Results: 1-25 | 26-50 | 51-75 | 76-80
Results: 1-25/80
(2S,4S)-2-AMINO-4-(2,2-DIPHENYLETHYL) PENTANEDIOIC ACID SELECTIVE GROUP 2 METABOTROPIC GLUTAMATE-RECEPTOR ANTAGONIST
Authors: ESCRIBANO A EZQUERRA J PEDREGAL C RUBIO A YRURETAGOYENA B BAKER SR WRIGHT RA JOHNSON BG SCHOEPP DD
Citation: A. Escribano et al., (2S,4S)-2-AMINO-4-(2,2-DIPHENYLETHYL) PENTANEDIOIC ACID SELECTIVE GROUP 2 METABOTROPIC GLUTAMATE-RECEPTOR ANTAGONIST, Bioorganic & medicinal chemistry letters, 8(7), 1998, pp. 765-770
HETEROATOM-SUBSTITUTION AS A STRATEGY FOR INCREASING THE POTENCY OF COMPETITIVE NMDA ANTAGONISTS
Authors: ORNSTEIN PL ARNOLD MB LUNN WHW HEINZ LJ LEANDER JD LODGE D SCHOEPP DD
Citation: Pl. Ornstein et al., HETEROATOM-SUBSTITUTION AS A STRATEGY FOR INCREASING THE POTENCY OF COMPETITIVE NMDA ANTAGONISTS, Bioorganic & medicinal chemistry letters, 8(4), 1998, pp. 389-394
3'-DISUBSTITUTED-2-(2'-CARBOXYCYCLOPROPYL)GLYCINES AS POTENT AND SELECTIVE ANTAGONISTS OF METABOTROPIC GLUTAMATE RECEPTORS
Authors: COLLADO I EZQUERRA J MAZON A PEDREGAL C YRURETAGOYENA B KINGSTON AE TOMLINSON R WRIGHT RA JOHNSON BG SCHOEPP DD
Citation: I. Collado et al., 3'-DISUBSTITUTED-2-(2'-CARBOXYCYCLOPROPYL)GLYCINES AS POTENT AND SELECTIVE ANTAGONISTS OF METABOTROPIC GLUTAMATE RECEPTORS, Bioorganic & medicinal chemistry letters, 8(20), 1998, pp. 2849-2854
SYNTHESIS AND METABOTROPIC GLUTAMATE-RECEPTOR ANTAGONIST ACTIVITY OF N-1-SUBSTITUTED ANALOGS OF 2R,4R-4-AMINOPYRROLIDINE-2,4-DICARBOXYLIC ACID
Authors: VALLI MJ SCHOEPP DD WRIGHT RA JOHNSON BG KINGSTON AE TOMLINSON R MONN JA
Citation: Mj. Valli et al., SYNTHESIS AND METABOTROPIC GLUTAMATE-RECEPTOR ANTAGONIST ACTIVITY OF N-1-SUBSTITUTED ANALOGS OF 2R,4R-4-AMINOPYRROLIDINE-2,4-DICARBOXYLIC ACID, Bioorganic & medicinal chemistry letters, 8(15), 1998, pp. 1985-1990
[H-3]LY341495, A HIGHLY POTENT, SELECTIVE AND NOVEL RADIOLIGAND FOR LABELING GROUP-II METABOTROPIC GLUTAMATE RECEPTORS
Authors: ORNSTEIN PL ARNOLD MB BLEISCH TJ WRIGHT RA WHEELER WJ SCHOEPP DD
Citation: Pl. Ornstein et al., [H-3]LY341495, A HIGHLY POTENT, SELECTIVE AND NOVEL RADIOLIGAND FOR LABELING GROUP-II METABOTROPIC GLUTAMATE RECEPTORS, Bioorganic & medicinal chemistry letters, 8(14), 1998, pp. 1919-1922
ACTIONS OF THE POTENT MGLU RECEPTOR ANTAGONIST LY341495 ON HIPPOCAMPAL LTD AND DEPOTENTIATION
Authors: FITZJOHN SM ORNSTEIN PL SCHOEPP DD KINGSTON AE LODGE D COLLINGRIDGE GL
Citation: Sm. Fitzjohn et al., ACTIONS OF THE POTENT MGLU RECEPTOR ANTAGONIST LY341495 ON HIPPOCAMPAL LTD AND DEPOTENTIATION, European journal of neuroscience, 10, 1998, pp. 5418-5418
ACTIONS OF LY341495, A POTENT MGLU RECEPTOR ANTAGONIST, ON HIPPOCAMPAL LTP
Authors: BERTOLOTTO ZA ORNSTEIN PL SCHOEPP DD KINGSTON AE LODGE D COLLINGRIDGE GL
Citation: Za. Bertolotto et al., ACTIONS OF LY341495, A POTENT MGLU RECEPTOR ANTAGONIST, ON HIPPOCAMPAL LTP, European journal of neuroscience, 10, 1998, pp. 9116-9116
EFFECTS OF THE SELECTIVE METABOTROPIC GLUTAMATE AGONIST LY354740 IN ARAT MODEL OF PERMANENT ISCHEMIA
Authors: LAM AGM SORIANO MA MONN JA SCHOEPP DD LODGE D MCCULLOCH J
Citation: Agm. Lam et al., EFFECTS OF THE SELECTIVE METABOTROPIC GLUTAMATE AGONIST LY354740 IN ARAT MODEL OF PERMANENT ISCHEMIA, Neuroscience letters, 254(2), 1998, pp. 121-123
GROUP-III HUMAN METABOTROPIC GLUTAMATE RECEPTOR-4, RECEPTOR-7 AND RECEPTOR-8 - MOLECULAR-CLONING, FUNCTIONAL EXPRESSION, AND COMPARISON OF PHARMACOLOGICAL PROPERTIES IN RGT CELLS
Authors: WU S WRIGHT RA ROCKEY PK BURGETT SG ARNOLD JS ROSTECK PR JOHNSON BG SCHOEPP DD BELAGAJE RM
Citation: S. Wu et al., GROUP-III HUMAN METABOTROPIC GLUTAMATE RECEPTOR-4, RECEPTOR-7 AND RECEPTOR-8 - MOLECULAR-CLONING, FUNCTIONAL EXPRESSION, AND COMPARISON OF PHARMACOLOGICAL PROPERTIES IN RGT CELLS, Molecular brain research, 53(1-2), 1998, pp. 88-97
LY341495 IS A NANOMOLAR POTENT AND SELECTIVE ANTAGONIST OF GROUP-II METABOTROPIC GLUTAMATE RECEPTORS
Authors: KINGSTON AE ORNSTEIN PL WRIGHT RA JOHNSON BG MAYNE NG BURNETT JP BELAGAJE R WU S SCHOEPP DD
Citation: Ae. Kingston et al., LY341495 IS A NANOMOLAR POTENT AND SELECTIVE ANTAGONIST OF GROUP-II METABOTROPIC GLUTAMATE RECEPTORS, Neuropharmacology, 37(1), 1998, pp. 1-12
POTENT, STEREOSELECTIVE, AND BRAIN REGION SELECTIVE MODULATION OF 2NDMESSENGERS IN THE RAT-BRAIN BY (-II METABOTROPIC GLUTAMATE-RECEPTOR AGONIST()LY354740, A NOVEL GROUP)
Authors: SCHOEPP DD JOHNSON BG WRIGHT RA SALHOFF CR MONN JA
Citation: Dd. Schoepp et al., POTENT, STEREOSELECTIVE, AND BRAIN REGION SELECTIVE MODULATION OF 2NDMESSENGERS IN THE RAT-BRAIN BY (-II METABOTROPIC GLUTAMATE-RECEPTOR AGONIST()LY354740, A NOVEL GROUP), Naunyn-Schmiedeberg's archives of pharmacology, 358(2), 1998, pp. 175-180
CURRENT PHARMACOLOGY OF METABOTROPIC GLUTAMATE-RECEPTOR SUBTYPES
Authors: SCHOEPP DD WRIGHT RA JOHNSON BG SALHOFF CR MAYNE NG BURNETT JP WU S MONN JA ORNSTEIN PL
Citation: Dd. Schoepp et al., CURRENT PHARMACOLOGY OF METABOTROPIC GLUTAMATE-RECEPTOR SUBTYPES, Naunyn-Schmiedeberg's archives of pharmacology, 358(1), 1998, pp. 73-73
ANXIOLYTIC AND SIDE-EFFECT PROFILE OF LY354740 - A POTENT, HIGHLY SELECTIVE, ORALLY-ACTIVE AGONIST FOR GROUP-II METABOTROPIC GLUTAMATE RECEPTORS
Authors: HELTON DR TIZZANO JP MONN JA SCHOEPP DD KALLMAN MJ
Citation: Dr. Helton et al., ANXIOLYTIC AND SIDE-EFFECT PROFILE OF LY354740 - A POTENT, HIGHLY SELECTIVE, ORALLY-ACTIVE AGONIST FOR GROUP-II METABOTROPIC GLUTAMATE RECEPTORS, The Journal of pharmacology and experimental therapeutics, 284(2), 1998, pp. 651-660
NOVEL LIGANDS FOR METABOTROPIC RECEPTORS
Authors: KINGSTON AE BAKER SR CLARK BP LODGE D MONN JA ONEILL MJ TIZZANO J SCHOEPP DD
Citation: Ae. Kingston et al., NOVEL LIGANDS FOR METABOTROPIC RECEPTORS, Journal of neurochemistry, 71, 1998, pp. 57-57
2-SUBSTITUTED MINO-2-((1SR,2SR)-2-CARBOXYCYCLOPROP-1-YL)GLYCINES AS POTENT AND SELECTIVE ANTAGONISTS OF GROUP-II METABOTROPIC GLUTAMATE RECEPTORS - 1 - EFFECTS OF ALKYL, ARYLALKYL, AND DIARYLALKYL SUBSTITUTION
Authors: ORNSTEIN PL BLEISCH TJ ARNOLD MB WRIGHT RA JOHNSON BG SCHOEPP DD
Citation: Pl. Ornstein et al., 2-SUBSTITUTED MINO-2-((1SR,2SR)-2-CARBOXYCYCLOPROP-1-YL)GLYCINES AS POTENT AND SELECTIVE ANTAGONISTS OF GROUP-II METABOTROPIC GLUTAMATE RECEPTORS - 1 - EFFECTS OF ALKYL, ARYLALKYL, AND DIARYLALKYL SUBSTITUTION, Journal of medicinal chemistry, 41(3), 1998, pp. 346-357
2-SUBSTITUTED MINO-2-((1SR,2SR)-2-CARBOXYCYCLOPROP-1-YL)GLYCINES AS POTENT AND SELECTIVE ANTAGONISTS OF GROUP-II METABOTROPIC GLUTAMATE RECEPTORS - 2 - EFFECTS OF AROMATIC-SUBSTITUTION, PHARMACOLOGICAL CHARACTERIZATION, AND BIOAVAILABILITY
Authors: ORNSTEIN PL BLEISCH TJ ARNOLD MB KENNEDY JH WRIGHT RA JOHNSON BG TIZZANO JP HELTON DR KALLMAN MJ SCHOEPP DD HERIN M
Citation: Pl. Ornstein et al., 2-SUBSTITUTED MINO-2-((1SR,2SR)-2-CARBOXYCYCLOPROP-1-YL)GLYCINES AS POTENT AND SELECTIVE ANTAGONISTS OF GROUP-II METABOTROPIC GLUTAMATE RECEPTORS - 2 - EFFECTS OF AROMATIC-SUBSTITUTION, PHARMACOLOGICAL CHARACTERIZATION, AND BIOAVAILABILITY, Journal of medicinal chemistry, 41(3), 1998, pp. 358-378
THE EFFECTS OF THE SELECTIVE GROUP-II METABOTROPIC GLUTAMATE-RECEPTORAGONIST LY354740 ON LOCAL CEREBRAL GLUCOSE-METABOLISM IN THE RAT-BRAIN
Authors: LAM AGM LODGE D MONN JA SCHOEPP DD MCCULLOCH J
Citation: Agm. Lam et al., THE EFFECTS OF THE SELECTIVE GROUP-II METABOTROPIC GLUTAMATE-RECEPTORAGONIST LY354740 ON LOCAL CEREBRAL GLUCOSE-METABOLISM IN THE RAT-BRAIN, British Journal of Pharmacology, 123, 1998, pp. 206-206
AMPA KAINATE ANTAGONIST LY293558 REDUCES CAPSAICIN-EVOKED HYPERALGESIA BUT NOT PAIN IN NORMAL SKIN IN HUMANS/
Authors: SANG CN HOSTETTER MP GRACELY RH CHAPPELL AS SCHOEPP DD LEE G WHITCUP S CARUSO R MAX MB
Citation: Cn. Sang et al., AMPA KAINATE ANTAGONIST LY293558 REDUCES CAPSAICIN-EVOKED HYPERALGESIA BUT NOT PAIN IN NORMAL SKIN IN HUMANS/, Anesthesiology, 89(5), 1998, pp. 1060-1067
STRUCTURE-ACTIVITY STUDIES OF ARYL-SPACED DECAHYDROISOQUINOLINE-3-CARBOXYLIC ACID AMPA RECEPTOR ANTAGONISTS
Authors: BLEISCH TJ ORNSTEIN PL ALLEN NK WRIGHT RA LODGE D SCHOEPP DD
Citation: Tj. Bleisch et al., STRUCTURE-ACTIVITY STUDIES OF ARYL-SPACED DECAHYDROISOQUINOLINE-3-CARBOXYLIC ACID AMPA RECEPTOR ANTAGONISTS, Bioorganic & medicinal chemistry letters, 7(9), 1997, pp. 1161-1166
IN-VIVO INHIBITION OF VERATRIDINE-EVOKED RELEASE OF STRIATAL EXCITATORY AMINO-ACIDS BY THE GROUP-II METABOTROPIC GLUTAMATE-RECEPTOR AGONISTLY354740 IN RATS
Authors: BATTAGLIA G MONN JA SCHOEPP DD
Citation: G. Battaglia et al., IN-VIVO INHIBITION OF VERATRIDINE-EVOKED RELEASE OF STRIATAL EXCITATORY AMINO-ACIDS BY THE GROUP-II METABOTROPIC GLUTAMATE-RECEPTOR AGONISTLY354740 IN RATS, Neuroscience letters, 229(3), 1997, pp. 161-164
LY354740 - A METABOTROPIC GLUTAMATE-RECEPTOR AGONIST WHICH AMELIORATES SYMPTOMS OF NICOTINE WITHDRAWAL IN RATS
Authors: HELTON DR TIZZANO JP MONN JA SCHOEPP DD KALLMAN MJ
Citation: Dr. Helton et al., LY354740 - A METABOTROPIC GLUTAMATE-RECEPTOR AGONIST WHICH AMELIORATES SYMPTOMS OF NICOTINE WITHDRAWAL IN RATS, Neuropharmacology, 36(11-12), 1997, pp. 1511-1516
LY354740 IS A POTENT AND HIGHLY SELECTIVE GROUP-II METABOTROPIC GLUTAMATE-RECEPTOR AGONIST IN CELLS EXPRESSING HUMAN GLUTAMATE RECEPTORS
Authors: SCHOEPP DD JOHNSON BG WRIGHT RA SALHOFF CR MAYNE NG WU S COCKERHAM SL BURNETT JP BELEGAJE R BLEAKMAN D MONN JA
Citation: Dd. Schoepp et al., LY354740 IS A POTENT AND HIGHLY SELECTIVE GROUP-II METABOTROPIC GLUTAMATE-RECEPTOR AGONIST IN CELLS EXPRESSING HUMAN GLUTAMATE RECEPTORS, Neuropharmacology, 36(1), 1997, pp. 1-11
A HIPPOCAMPAL GLUR5 KAINATE RECEPTOR REGULATING INHIBITORY SYNAPTIC TRANSMISSION
Authors: CLARKE VRJ BALLYK BA HOO KH MANDELZYS A PELLIZZARI A BATH CP THOMAS J SHARPE EF DAVIES CH ORNSTEIN PL SCHOEPP DD KAMBOJ RK COLLINGRIDGE GL LODGE D BLEAKMAN D
Citation: Vrj. Clarke et al., A HIPPOCAMPAL GLUR5 KAINATE RECEPTOR REGULATING INHIBITORY SYNAPTIC TRANSMISSION, Nature, 389(6651), 1997, pp. 599-603
DESIGN, SYNTHESIS, AND PHARMACOLOGICAL CHARACTERIZATION OF (-2-AMINOBICYCLO[3.1.0]HEXANE-2,6-DICARBOXYLIC ACID (LY354740) - A POTENT, SELECTIVE, AND ORALLY-ACTIVE GROUP-2 METABOTROPIC GLUTAMATE-RECEPTOR AGONIST POSSESSING ANTICONVULSANT AND ANXIOLYTIC PROPERTIES())
Authors: MONN JA VALLI MJ MASSEY SM WRIGHT RA SALHOFF CR JOHNSON BG HOWE T ALT CA RHODES GA ROBEY RL GRIFFEY KR TIZZANO JP KALLMAN MJ HELTON DR SCHOEPP DD
Citation: Ja. Monn et al., DESIGN, SYNTHESIS, AND PHARMACOLOGICAL CHARACTERIZATION OF (-2-AMINOBICYCLO[3.1.0]HEXANE-2,6-DICARBOXYLIC ACID (LY354740) - A POTENT, SELECTIVE, AND ORALLY-ACTIVE GROUP-2 METABOTROPIC GLUTAMATE-RECEPTOR AGONIST POSSESSING ANTICONVULSANT AND ANXIOLYTIC PROPERTIES()), Journal of medicinal chemistry, 40(4), 1997, pp. 528-537
SELECTIVE PROTECTION AGAINST AMPA-EVOKED AND KAINATE-EVOKED NEUROTOXICITY BY ZOLE-5-YL)ETHYL]DECAHYDROISOQUINOLINE-3-CARBOXYLIC ACID (LY293558) AND ITS RACEMATE (LY215490)
Authors: SCHOEPP DD SALHOFF CR FUSON KS SACAAN AI TIZZANO JP ORNSTEIN PL MAY PC
Citation: Dd. Schoepp et al., SELECTIVE PROTECTION AGAINST AMPA-EVOKED AND KAINATE-EVOKED NEUROTOXICITY BY ZOLE-5-YL)ETHYL]DECAHYDROISOQUINOLINE-3-CARBOXYLIC ACID (LY293558) AND ITS RACEMATE (LY215490), Journal of neural transmission, 103(8-9), 1996, pp. 905-916
Risultati: 1-25 | 26-50 | 51-75 | 76-80